statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investors in Immunovant Inc (IMVT) saw new options begin trading this week, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IMVT options...

Interesting IMVT Put And Call Options For May 10th

Oppenheimer assumed coverage on shares of Immunovant (NASDAQ:IMVT - Free Report) in a report published on Thursday, MarketBeat reports. The brokerage issued an outperform rating and a $50.00 target...

Immunovant (NASDAQ:IMVT) Research Coverage Started at Oppenheimer

This indicator may be signaling IMVT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Immunovant (IMVT, $32.51) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

This indicator may be signaling that IMVT's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Immunovant (IMVT, $31.22) entered Downtrend as Momentum indicator drops below 0 level on Mar 25, 2024

Gagnants
Le titre Yield10 Bioscience (NASDAQ:YTEN) a augment jeudi de 200,08% 0,73 dollars lors de la session pre-market.
Le titre argenx (NASDAQ:ARGX) a mont de 14,86% 410 dollars.
Le titre...

12 titres de soins de sant  en mouvement lors de la pr -ouverture le 21/03/2024

Acciones al alza
Yield10 Bioscience (NASDAQ:YTEN) experimentaron un repunte del 156,58% para establecerse en los 0,62 d lares durante la sesi n del pre-market del jueves.
Immunovant (NASDAQ:IMVT...

12 acciones de salud en movimiento durante la preapertura del 21/03/2024

This is a signal that IMVT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Immunovant (IMVT, $31.09) RSI Indicator left the oversold zone on March 19, 2024

Equities research analysts at The Goldman Sachs Group initiated coverage on shares of Immunovant (NASDAQ:IMVT  Get Free Report) in a report issued on Wednesday, MarketBeat.com reports. The...

Immunovant (NASDAQ:IMVT) Receives New Coverage from Analysts at The Goldman Sachs Group

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Immunovant Inc (IMVT), where a total of 5,684 contracts have traded so far, representing...

Notable Thursday Option Activity: IMVT, DBRG, TITN

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Immunovant awarded U.S. patent for IMVT-1402

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.

Watchers	1,975
52-Wk Low	$17.53
52-Wk High	$45.58

Volume	1.27M
52-Wk High	$45.58
52-Wk Low	$17.53

IMVT Immunovant Inc

About

Feed

News

Sentiment

Earnings

Fundamentals